Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study

Vansteenkiste, Jf; Canon, Jl; De Braud, F; Grossi, F; De Pas, T; Gray, Je; Su, Wc; Felip, E; Yoshioka, H; Gridelli, C; Dy, Gk; Thongprasert, S; Reck, M; Aimone, P; Vidam GA, ; Roussou, P; Wang, Ya; Di Tomaso, E; Soria, Jc